- Home
- IVR vs LXEO Comparison
IVR vs LXEO Comparison
Compare IVR & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IVR | LXEO |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.3M | 731.3M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | IVR | LXEO |
|---|---|---|
| Price | $8.51 | $6.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $8.25 | ★ $18.60 |
| AVG Volume (30 Days) | ★ 2.5M | 726.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 17.16% | N/A |
| EPS Growth | N/A | ★ 75.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $654,000.00 |
| Revenue This Year | $150.63 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.63 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.86 | $1.45 |
| 52 Week High | $9.50 | $10.99 |
Technical Indicators
Market Signals| Indicator | IVR | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 43.11 | 44.85 |
| Support Level | $7.16 | $6.15 |
| Resistance Level | $9.10 | $7.87 |
| Average True Range (ATR) | 0.19 | 0.41 |
| MACD | -0.05 | 0.10 |
| Stochastic Oscillator | 31.96 | 57.14 |
Price Performance
Historical ComparisonAbout IVR INVESCO MORTGAGE CAPITAL INC
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.